[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Novel Oral AntiCoagulants (NOAC) Market Report 2016

October 2016 | 123 pages | ID: U8AA7C113A9EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Novel Oral AntiCoagulants (NOAC)

Revenue, means the sales value of Novel Oral AntiCoagulants (NOAC)

This report studies sales (consumption) of Novel Oral AntiCoagulants (NOAC) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Pfizer, Inc. (US)
  • Bayer Healthcare AG (Germany)
  • GlaxoSmithKline Plc. (UK)
  • Boehringer Ingelheim (Germany)
  • Sanofi S.A. (France)
  • Abbott India Limited (India)
  • Aspen Holdings (South Africa)
  • Bristol-Myers Squibb Company (US)
  • Eisai Inc. (US)
  • Mitsubishi Tanabe Pharma Corporation (Japan)
  • Teva Pharmaceutical Industries Ltd. (Israel)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Novel Oral AntiCoagulants (NOAC) in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Novel Oral AntiCoagulants (NOAC) Market Report 2016

1 NOVEL ORAL ANTICOAGULANTS (NOAC) OVERVIEW

1.1 Product Overview and Scope of Novel Oral AntiCoagulants (NOAC)
1.2 Classification of Novel Oral AntiCoagulants (NOAC)
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Novel Oral AntiCoagulants (NOAC)
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Novel Oral AntiCoagulants (NOAC) (2011-2021)
  1.4.1 United States Novel Oral AntiCoagulants (NOAC) Sales and Growth Rate (2011-2021)
  1.4.2 United States Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2011-2021)

2 UNITED STATES NOVEL ORAL ANTICOAGULANTS (NOAC) COMPETITION BY MANUFACTURERS

2.1 United States Novel Oral AntiCoagulants (NOAC) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Novel Oral AntiCoagulants (NOAC) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Novel Oral AntiCoagulants (NOAC) Average Price by Manufactures (2015 and 2016)
2.4 Novel Oral AntiCoagulants (NOAC) Market Competitive Situation and Trends
  2.4.1 Novel Oral AntiCoagulants (NOAC) Market Concentration Rate
  2.4.2 Novel Oral AntiCoagulants (NOAC) Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NOVEL ORAL ANTICOAGULANTS (NOAC) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Novel Oral AntiCoagulants (NOAC) Sales and Market Share by Type (2011-2016)
3.2 United States Novel Oral AntiCoagulants (NOAC) Revenue and Market Share by Type (2011-2016)
3.3 United States Novel Oral AntiCoagulants (NOAC) Price by Type (2011-2016)
3.4 United States Novel Oral AntiCoagulants (NOAC) Sales Growth Rate by Type (2011-2016)

4 UNITED STATES NOVEL ORAL ANTICOAGULANTS (NOAC) SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Novel Oral AntiCoagulants (NOAC) Sales and Market Share by Application (2011-2016)
4.2 United States Novel Oral AntiCoagulants (NOAC) Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES NOVEL ORAL ANTICOAGULANTS (NOAC) MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Novel Oral AntiCoagulants (NOAC) Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Novel Oral AntiCoagulants (NOAC) Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Novel Oral AntiCoagulants (NOAC) Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Novel Oral AntiCoagulants (NOAC) Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Novel Oral AntiCoagulants (NOAC) Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Novel Oral AntiCoagulants (NOAC) Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Novel Oral AntiCoagulants (NOAC) Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Novel Oral AntiCoagulants (NOAC) Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Novel Oral AntiCoagulants (NOAC) Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Novel Oral AntiCoagulants (NOAC) Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 NOVEL ORAL ANTICOAGULANTS (NOAC) MANUFACTURING COST ANALYSIS

6.1 Novel Oral AntiCoagulants (NOAC) Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Novel Oral AntiCoagulants (NOAC)

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Novel Oral AntiCoagulants (NOAC) Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Novel Oral AntiCoagulants (NOAC) Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES NOVEL ORAL ANTICOAGULANTS (NOAC) MARKET FORECAST (2016-2021)

10.1 United States Novel Oral AntiCoagulants (NOAC) Sales, Revenue Forecast (2016-2021)
10.2 United States Novel Oral AntiCoagulants (NOAC) Sales Forecast by Type (2016-2021)
10.3 United States Novel Oral AntiCoagulants (NOAC) Sales Forecast by Application (2016-2021)
10.4 Novel Oral AntiCoagulants (NOAC) Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Novel Oral AntiCoagulants (NOAC)
Table Classification of Novel Oral AntiCoagulants (NOAC)
Figure United States Sales Market Share of Novel Oral AntiCoagulants (NOAC) by Type in 2015
Table Application of Novel Oral AntiCoagulants (NOAC)
Figure United States Sales Market Share of Novel Oral AntiCoagulants (NOAC) by Application in 2015
Figure United States Novel Oral AntiCoagulants (NOAC) Sales and Growth Rate (2011-2021)
Figure United States Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2011-2021)
Table United States Novel Oral AntiCoagulants (NOAC) Sales of Key Manufacturers (2015 and 2016)
Table United States Novel Oral AntiCoagulants (NOAC) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Novel Oral AntiCoagulants (NOAC) Sales Share by Manufacturers
Figure 2016 Novel Oral AntiCoagulants (NOAC) Sales Share by Manufacturers
Table United States Novel Oral AntiCoagulants (NOAC) Revenue by Manufacturers (2015 and 2016)
Table United States Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers
Table 2016 United States Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers
Table United States Market Novel Oral AntiCoagulants (NOAC) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Novel Oral AntiCoagulants (NOAC) Average Price of Key Manufacturers in 2015
Figure Novel Oral AntiCoagulants (NOAC) Market Share of Top 3 Manufacturers
Figure Novel Oral AntiCoagulants (NOAC) Market Share of Top 5 Manufacturers
Table United States Novel Oral AntiCoagulants (NOAC) Sales by Type (2011-2016)
Table United States Novel Oral AntiCoagulants (NOAC) Sales Share by Type (2011-2016)
Figure United States Novel Oral AntiCoagulants (NOAC) Sales Market Share by Type in 2015
Table United States Novel Oral AntiCoagulants (NOAC) Revenue and Market Share by Type (2011-2016)
Table United States Novel Oral AntiCoagulants (NOAC) Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Novel Oral AntiCoagulants (NOAC) by Type (2011-2016)
Table United States Novel Oral AntiCoagulants (NOAC) Price by Type (2011-2016)
Figure United States Novel Oral AntiCoagulants (NOAC) Sales Growth Rate by Type (2011-2016)
Table United States Novel Oral AntiCoagulants (NOAC) Sales by Application (2011-2016)
Table United States Novel Oral AntiCoagulants (NOAC) Sales Market Share by Application (2011-2016)
Figure United States Novel Oral AntiCoagulants (NOAC) Sales Market Share by Application in 2015
Table United States Novel Oral AntiCoagulants (NOAC) Sales Growth Rate by Application (2011-2016)
Figure United States Novel Oral AntiCoagulants (NOAC) Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Novel Oral AntiCoagulants (NOAC) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Novel Oral AntiCoagulants (NOAC) Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Novel Oral AntiCoagulants (NOAC)
Figure Manufacturing Process Analysis of Novel Oral AntiCoagulants (NOAC)
Figure Novel Oral AntiCoagulants (NOAC) Industrial Chain Analysis
Table Raw Materials Sources of Novel Oral AntiCoagulants (NOAC) Major Manufacturers in 2015
Table Major Buyers of Novel Oral AntiCoagulants (NOAC)
Table Distributors/Traders List
Figure United States Novel Oral AntiCoagulants (NOAC) Production and Growth Rate Forecast (2016-2021)
Figure United States Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate Forecast (2016-2021)
Table United States Novel Oral AntiCoagulants (NOAC) Production Forecast by Type (2016-2021)
Table United States Novel Oral AntiCoagulants (NOAC) Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories